Neovascular (Wet) Age-Related Macular Degeneration Clinical Trials

26 clinical trials for Neovascular (Wet) Age-Related Macular Degeneration across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration — RECRUITING · PHASE1
• 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration — RECRUITING · PHASE1
• A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD — RECRUITING
• OCT Angiography in Wet AMD — RECRUITING
• A PHASE II RANDOMIZED, DOUBLE-MASKED, STUDY COMPARING THE SAFETY AND EFFICACY OF ATG003 (MECAMYLAMINE HCL) 1.0% and 0.3% OPHTHALMIC SOLUTIONS TO PLACEBO IN PATIENTS WITH NEOVASCULAR ("WET") AGE-RELATED MACULAR DEGENERATION (NV-AMD) — TERMINATED · PHASE2
• Evaluation of PAN-90806 Eye Drops in Healthy Subjects — NOT_YET_RECRUITING · PHASE1
• First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD) — NOT_YET_RECRUITING · PHASE1
• Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy — COMPLETED · PHASE2
• AI vs. Physician for Anti-VEGF Decision-Making: An RCT — NOT_YET_RECRUITING · NA
• Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates — NOT_YET_RECRUITING · NA
• Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration — NOT_YET_RECRUITING · PHASE2
• A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU) — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of EXG102-031 in Patients With wAMD (Everest) — COMPLETED · PHASE1
• A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 — COMPLETED · PHASE1
• Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration — ACTIVE_NOT_RECRUITING
• Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration — COMPLETED · PHASE3
• A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] — COMPLETED · PHASE3
• Stereotactic Radiotherapy for Wet AMD (STAR) — COMPLETED · PHASE3
• Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD — ACTIVE_NOT_RECRUITING
• The Effect of Phacoemulsification on the Macular Changes in Patients with Neovascular Age-related Macular Degeneration — NOT_YET_RECRUITING
• A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment — TERMINATED · PHASE4
• Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) — COMPLETED
• Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration — COMPLETED · PHASE2
• A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration — COMPLETED · PHASE3
• Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications — COMPLETED
• Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD — COMPLETED · PHASE1

Refine this search